Structural Remodeling in Atrium can be Suppressed by Febuxostat, a Xanthine?Oxidase -Inhibitor, in the Canine Model of Atrial Fibrillation.
Heart Rhythm 2015
Heart RhythmSociety, USA
Boston, USA